Cross-reactive CD4

Autor:	Lucie, Loyal, Julian, Braun, Larissa, Henze, Beate, Kruse, Manuela, Dingeldey, Ulf, Reimer, Florian, Kern, Tatjana, Schwarz, Maike, Mangold, Clara, Unger, Friederike, Dörfler, Shirin, Kadler, Jennifer, Rosowski, Kübrah, Gürcan, Zehra, Uyar-Aydin, Marco, Frentsch, Florian, Kurth, Karsten, Schnatbaum, Maren, Eckey, Stefan, Hippenstiel, Andreas, Hocke, Marcel A, Müller, Birgit, Sawitzki, Stefan, Miltenyi, Friedemann, Paul, Marcus A, Mall, Holger, Wenschuh, Sebastian, Voigt, Christian, Drosten, Roland, Lauster, Nils, Lachman, Leif-Erik, Sander, Victor M, Corman, Jobst, Röhmel, Lil, Meyer-Arndt, Andreas, Thiel, Claudia, Giesecke-Thiel
Rok vydání:	2021
Předmět:	Adult Aged 80 and over CD4-Positive T-Lymphocytes Male COVID-19 Vaccines CD3 Complex Immunodominant Epitopes SARS-CoV-2 Vaccination Age Factors Immunity COVID-19 Cross Reactions Middle Aged Peptide Fragments Open Reading Frames Young Adult Asymptomatic Diseases Spike Glycoprotein Coronavirus Humans Female BNT162 Vaccine Aged
Zdroj:	Science (New York, N.Y.). 374(6564)
ISSN:	1095-9203
Popis:	The functional relevance of preexisting cross-immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a subject of intense debate. Here, we show that human endemic coronavirus (HCoV)–reactive and SARS-CoV-2–cross-reactive CD4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::0c802b5287dbcc8ef215917a76ed231a https://pubmed.ncbi.nlm.nih.gov/34465633 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.